Latvia - Import of Heterocyclic Compounds with Unfused Imidazole Ring

Since 2014, Latvia Import of Heterocyclic Compounds with Unfused Imidazole Ring grew 105.8% year on year. In 2019, the country was ranked number 75 comparing other countries in Import of Heterocyclic Compounds with Unfused Imidazole Ring with $978,042.98. Latvia is overtaken by Moldova, which was number 74 with $1,000,494 and is followed by Jordan at $965,390.14. United States topped the ranking with $239,540,700.09 in 2019, an increase of 112.7% compared to 2018. United Kingdom, Ireland and Japan respectively ranked number 2, 3 and 4 in this ranking. Oman witnessed the best average annual growth at +292.6% per year, while Iceland recorded the worst performance at -74.1% per year.

Loading...

Date US Dollars
2019 978,042.98
2018 1,116,101.13
2017 392,717.78
2016 278,220.63
2015 172,996.31
Download all data from 1995 to 2019

How does Latvia rank in Import of Heterocyclic Compounds with Unfused Imidazole Ring?

# 137 Countries US Dollars Last YoY 5‑years CAGR
1 #1
United States
239,540,700.09 2019 +112.7 % +5.1 % View data
2 #2
United Kingdom
215,981,067.13 2019 -9.7 % +5.1 % View data
74 #74
Moldova
1,000,494.00 2019 +36.8 % -17.4 % View data
75 #75
Latvia
978,042.98 2019 -12.4 % +105.8 % View data
76 #76
Jordan
965,390.14 2019 -8.9 % -15.6 % View data
Compare all 137 countries

Go Top